Adagio Therapeutics Initiates Global Clinical Trial of ADG20 as a Treatment for COVID-19

Retrieved on: 2021-04-13 10:30:00

Tags for this article:

Click the tags to see associated articles and topics

Adagio Therapeutics Initiates Global Clinical Trial of ADG20 as a Treatment for COVID-19. View article details on hiswai:

Excerpt

ADG20, a monoclonal antibody targeting the spike protein of SARS-CoV-2 and related coronaviruses, is being developed for the prevention and ...

Article found on: www.biospace.com